Ttc39b | tetratricopeptide repeat domain 39B
Physiological systems
19 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Skeleton
17 No significant impact
5 Not tested
Data collections
Viability data
Body weight measurements
Embryo imaging data
Body weight measurements
Embryo imaging data
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
increased bone mineral density | 1 supporting dataset | Ttc39btm1e(EUCOMM)Wtsi | homozygote | Early adult | 9.29x10-5 | ||
increased bone mineral content | 1 supporting dataset | Ttc39btm1e(EUCOMM)Wtsi | heterozygote | Early adult | 1.06x10-5 | ||
decreased circulating triglyceride level | 1 supporting dataset | Ttc39btm1e(EUCOMM)Wtsi | heterozygote | Early adult | 3.21x10-5 |
| | | | | | | | | |
External links
No external links available for Ttc39b.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Ttc39btm1a(EUCOMM)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Ttc39btm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell mouse |
Ttc39btm36268(L1L2_gt0) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |